Results 171 to 180 of about 8,581 (204)

PULMONARY ALVEOLAR PROTEINOSIS

Annals of Internal Medicine, 1960
Excerpt Pulmonary alveolar proteinosis was first described by Rosen et al. in June, 1958.1We have had the opportunity to observe a patient with this disease, and wish to report the clinical, labora...
W R, EDMONDSON, J B, GERE
  +7 more sources

Pulmonary Alveolar Proteinosis

Critical Reviews in Computed Tomography, 2003
Case 1: A 52-year-old Caucasian retired police officer presented 3 years prior to diagnosis with the chief complaint of inability to exercise due to breathlessness. The patient was a long-distance walker who had given up this recreational activity due to dyspnea on exertion.
Bruce C, Trapnell, Jeffrey A, Whitsett, Koh, Nakata   +2 more
openaire   +4 more sources

Pulmonary Alveolar Proteinosis

New England Journal of Medicine, 1958
WITHIN the past five years, and at an increasing rate within recent months, we have encountered 27 cases of a remarkable disease of the lung that consists of the filling of the alveoli by a PAS-positive proteinaceous material, rich in lipid. This material appears to be produced by the lining cells, which slough into the lumen, ultimately becoming ...
Samuel H. Rosen, Benjamin Castleman, Averill A. Liebow, Frank M. Enzinger, Richard T. N. Hunt   +4 more
openaire   +3 more sources

Autoimmune Pulmonary Alveolar Proteinosis

American Journal of Respiratory and Critical Care Medicine, 2022
Autoimmune pulmonary alveolar proteinosis (PAP) is a rare disease characterized by myeloid cell dysfunction, abnormal pulmonary surfactant accumulation, and innate immune deficiency. It has a prevalence of 7-10 per million; occurs in individuals of all races, geographic regions, sex, and socioeconomic status; and accounts for 90% of all patients with ...
Cormac McCarthy, Brenna C. Carey, Bruce C. Trapnell   +2 more
openaire   +2 more sources

Pulmonary Alveolar Proteinosis Syndrome

Seminars in Respiratory and Critical Care Medicine, 2020
AbstractPulmonary alveolar proteinosis (PAP) is a syndrome characterized by progressive accumulation of pulmonary surfactant. This results in dyspnea, secondary pulmonary and systemic infection, and in some cases respiratory failure. PAP syndrome occurs in distinct diseases, classified according to pathogenetic mechanism; these include primary PAP (due
Alan, Kelly, Cormac, McCarthy
openaire   +2 more sources

Asymptomatic pulmonary alveolar proteinosis

The American Journal of Medicine, 1960
Abstract A case of pulmonary alveolar proteinosis is described, and corroborative data including representative radiographs and photomicrographs of the biopsy specimen of the lung are presented. The majority of patients discussed in the original monograph by Rosen et al. were symptomatic.
W E, FURST, B M, BELL, G V, IRONS
openaire   +2 more sources

PULMONARY ALVEOLAR PROTEINOSIS

The Lancet, 1965
R A, GOODBODY, J M, DAVIDSON
  +7 more sources

Pulmonary alveolar proteinosis

The Indian Journal of Pediatrics, 1993
A, al Khayat, S, Nafday
openaire   +2 more sources

Paraneoplastic Pulmonary Alveolar Proteinosis

American Journal of Respiratory and Critical Care Medicine, 2022
Mark Leick, Yi-Bin Chen
openaire   +2 more sources

PULMONARY ALVEOLAR PROTEINOSIS

Medical Journal of Australia, 1963
W J, PHILLIPS, T J, CONSTANCE
openaire   +2 more sources